Unexpected TBEV seropositivity in serbian patients who recovered from viral meningitis and encephalitis

View/ Open
Date
2022Author
Banović, Pavle
Díaz-Sánchez, Adrian Alberto
Đurić, Selena
Sević, Siniša
Turkulov , Vesna
Lendak, Dajana
Stefan Mikić, Sandra
Simin, Verica
Mijatović, Dragana
Bogdan, Ivana
Potkonjak, Aleksandar
Savić, Sara
Obregón, Dasiel
Cabezas-Cruz, Alejandro
Metadata
Show full item recordAbstract
The tick-borne encephalitis virus (TBEV) causes a life-threatening disease named Tickborne
encephalitis (TBE). The clinical symptoms associated with TBE range from non-specific to
severe inflammation of the central nervous system and are very similar to the clinical presentation
of other viral meningitis/encephalitis. In consequence, TBE is often misclassified by clinical physicians,
mainly in the non-identified high-risk areas where none or only a few TBE cases have been
reported. Considering this situation, we hypothesized that among persons from northern Serbia
who recovered from viral meningitis or encephalitis, there would be evidence of TBEV infection.
To test this hypothesis, in this observational study, we evaluated the seroreactivity against TBEV
antigens in patients from northern Serbia who were hospitalized due to viral meningitis and/or viral
encephalitis of unknown etiology. Three cases of seroreactivity to TBEV antigens were discovered
among convalescent patients who recovered from viral meningitis and/or encephalitis and accepted
to participate in the study (n = 15). The clinical and laboratory findings of these patients overlap with
that of seronegative convalescent patients. Although TBE has been a notifiable disease in Serbia since
2004, there is no active TBE surveillance program for the serologic or molecular screening of TBEV
infection in humans in the country. This study highlights the necessity to increase the awareness
of TBE among physicians and perform active and systematic screening of TBEV antibodies among
patients with viral meningitis and/or encephalitis.